BLISS JENSEN: Open Payments
NPI 1588154470 · VANCOUVER, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,826 in 117 payments from 26 companies in 2025. Trend: 2023 $1,872 · 2024 $2,809 · 2025 $2,826
Food & beverage: $2,826
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 20 | $344 |
| AstraZeneca Pharmaceuticals LP | 12 | $314 |
| ABBVIE INC. | 15 | $296 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $279 |
| Novo Nordisk Inc | 7 | $251 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $203 |
| Lilly USA, LLC | 6 | $195 |
| Amgen Inc. | 10 | $178 |
| Astellas Pharma US Inc | 4 | $84 |
| Corcept Therapeutics | 3 | $78 |
Products named: XIFAXAN, QULIPTA, Ozempic, CAPLYTA, AIRSUPRA, ZEPBOUND, NURTEC ODT, EVENITY.
Industry payments across WA — which companies pay providers there.
